Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles

De Clercq, 2013, Antivirals: past, present and future, Biochem Pharmacol, 85, 727, 10.1016/j.bcp.2012.12.011 Shattock, 2011, AIDS. Turning the tide against HIV, Science, 333, 42, 10.1126/science.1206399 Cilento, 2021, Avoiding drug resistance in HIV reverse transcriptase, Chem Rev, 121, 3271, 10.1021/acs.chemrev.0c00967 Li, 2022, Approved HIV reverse transcriptase inhibitors in the past decade, Acta Pharm Sin B, 12, 1567, 10.1016/j.apsb.2021.11.009 Zhuang, 2020, Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years, Acta Pharm Sin B, 10, 961, 10.1016/j.apsb.2019.11.010 Schrijvers, 2013, Etravirine for the treatment of HIV/AIDS, Expet Opin Pharmacother, 14, 1087, 10.1517/14656566.2013.787411 Rai, 2018, Emerging reverse transcriptase inhibitors for HIV-1 infection, Expet Opin Emerg Drugs, 23, 149, 10.1080/14728214.2018.1474202 Chen, 2004, Drug resistance, virus fitness and HIV-1 mutagenesis, Curr Pharmaceut Des, 10, 4065, 10.2174/1381612043382404 Menéndez-Arias, 2009, Mutation rates and intrinsic fidelity of retroviral reverse transcriptases, Viruses, 1, 1137, 10.3390/v1031137 Menéndez-Arias, 2010, Molecular basis of human immunodeficiency virus drug resistance: an update, Antivir Res, 85, 210, 10.1016/j.antiviral.2009.07.006 Benedicto, 2021, NNRTI and liver damage: evidence of their association and the mechanisms involved, Cells, 10, 1687, 10.3390/cells10071687 Famiglini, 2018, Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors, Antivir Chem Chemother, 26, 10.1177/2040206617753443 Silvestri, 2003, Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies, J Med Chem, 46, 2482, 10.1021/jm0211063 Zhao, 2019, Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing, Eur J Med Chem, 182, 10.1016/j.ejmech.2019.111619 Li, 2017, Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement, Eur J Med Chem, 126, 190, 10.1016/j.ejmech.2016.10.009 La Regina, 2011, Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide, J Med Chem, 54, 1587, 10.1021/jm101614j Gao, 2022, Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features, Eur J Med Chem, 238, 10.1016/j.ejmech.2022.114471 Young, 1995, 2-Heterocyclic indole-3-sulfones as inhibitors of HIV-1 reverse transcriptase, Bioorg Med Chem Lett, 5, 491, 10.1016/0960-894X(95)00059-3 Zhao, 2008, Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs), Bioorg Med Chem Lett, 18, 554, 10.1016/j.bmcl.2007.11.085 Kang, 2021, 2,4,5-Trisubstituted pyrimidines as potent HIV-1 NNRTIs: rational design, synthesis, activity evaluation, and crystallographic studies, J Med Chem, 64, 4239, 10.1021/acs.jmedchem.1c00268 Arabi, 2017, Routes to drug design via bioisosterism of carboxyl and sulfonamide groups, Future Med Chem, 9, 2167, 10.4155/fmc-2017-0136 Mustafa, 2022, The importance of sulfur-containing motifs in drug design and discovery, Expet Opin Drug Discov, 17, 501, 10.1080/17460441.2022.2044783 Supuran, 2004, Antiviral sulfonamide derivatives, Mini Rev Med Chem, 4, 189, 10.2174/1389557043487402 Sun, 2015, Identification of the novel N-phenylbenzenesulfonamide derivatives as potent HIV inhibitors, Chin Chem Lett, 26, 243, 10.1016/j.cclet.2014.11.004 Han, 2020, Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors, Chin Chem Lett, 31, 764, 10.1016/j.cclet.2019.11.020 Gulçin, 2018, Sulfonamide inhibitors: a patent review 2013-present, Expert Opin Ther Pat, 28, 541, 10.1080/13543776.2018.1487400 Zhan, 2008, Recent advances in antiviral activity of benzo/heterothiadiazine dioxide derivatives, Curr Med Chem, 15, 1529, 10.2174/092986708784638898 Sun, 2020, Design, synthesis, and mechanism study of benzenesulfonamide-containing phenylalanine derivatives as novel HIV-1 capsid inhibitors with improved antiviral activities, J Med Chem, 63, 4790, 10.1021/acs.jmedchem.0c00015 Ren, 2020, Discovery and optimization of benzenesulfonamides-based hepatitis B virus capsid modulators via contemporary medicinal chemistry strategies, Eur J Med Chem, 206, 10.1016/j.ejmech.2020.112714 Kang, 2018, Further exploring solvent-exposed tolerant regions of allosteric binding pocket for novel HIV-1 NNRTIs discovery, ACS Med Chem Lett, 9, 370, 10.1021/acsmedchemlett.8b00054 Kang, 2020, Structure-based bioisosterism yields HIV-1 NNRTIs with improved drug-resistance profiles and favorable pharmacokinetic properties, J Med Chem, 63, 4837, 10.1021/acs.jmedchem.0c00117 HIV Drug Resistance Database. NNRTI Resistance Notes. Accessed 27 November 2022. Available from: https://hivdb.stanford.edu/dr-summary/resistance-notes/NNRTI/.